ArticleJournal for immunotherapy of cancer2023

Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival.

Luigi D'Antonio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.